BioCryst Pharmaceuticals, Inc. (BCRX)
8.62
-0.28
(-3.15%)
USD |
NASDAQ |
May 08, 16:00
8.62
0.00 (0.00%)
Pre-Market: 20:00
BioCryst Pharmaceuticals Market Cap : 2.191B for May 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anika Therapeutics, Inc. | 196.52M |
| KalVista Pharmaceuticals, Inc. | 1.421B |
| Revolution Medicines, Inc. | 30.15B |
| Plus Therapeutics, Inc. | 42.00M |
| Perspective Therapeutics, Inc. | 428.39M |
Market Cap Related Metrics
| PS Ratio | 2.193 |
| PEG Ratio | -0.0083 |
| Price to Free Cash Flow | 6.628 |
| Price | 8.62 |
| Earnings Yield | -20.61% |
| PEGY Ratio | -0.0083 |
| Operating PE Ratio | 6.148 |
| Normalized PE Ratio | 28.81 |